Originally published In Press as doi:10.1074/jbc.M405777200 on August 2, 2004
J. Biol. Chem., Vol. 279, Issue 41, 43352-43360, October 8, 2004
p38 MAPK Mediates
-Irradiation-induced Endothelial Cell Apoptosis, and Vascular Endothelial Growth Factor Protects Endothelial Cells through the Phosphoinositide 3-Kinase-Akt-Bcl-2 Pathway*
Pawan Kumar
,
April I. Miller
, and
Peter J. Polverini
¶
From the
Department of Oral Medicine, Pathology, and Oncology, University of Michigan School of Dentistry, Ann Arbor, Michigan 48109 and the
Department of Oral Sciences, University of Minnesota School of Dentistry, Minneapolis, Minnesota 55455
Therapeutic radiation is widely used in cancer treatments. The success of radiation therapy depends not only on the radiosensitivity of tumor cells but also on the radiosensitivity of endothelial cells lining the tumor vasculature. Vascular endothelial growth factor (VEGF) plays a critical role in protecting endothelial cells against a number of antitumor agents including ionizing radiation. Strategies designed to overcome the survival advantage afforded to endothelial cells by VEGF might aid in enhancing the efficacy of radiation therapy. In this report we examined the signaling cascade(s) involved in VEGF-mediated protection of endothelial cells against
-irradiation.
-Irradiation-induced apoptosis of human dermal microvascular endothelial cells (HDMECs) was predominantly mediated through the p38 MAPK pathway as an inhibitor of p38 MAPK (PD169316), and dominant negative mutants of p38 MAPK could significantly enhance HDMEC survival against
-irradiation. Inhibition of the PI3K and MAPK pathways markedly up-regulated
-irradiation-mediated p38 MAPK activation resulting in enhanced HDMEC apoptosis. In contrast, VEGF-treated HDMECs were protected from
-irradiation-induced apoptosis predominantly through the PI3K/Akt pathway. Bcl-2 expression was markedly elevated in VEGF-treated HDMECs, and it was significantly inhibited by the PI3K inhibitor LY294002. HDMECs exposed to irradiation showed a significant decrease in Bcl-2 expression. In contrast, VEGF-stimulated HDMECs, when irradiated, maintained higher levels of Bcl-2 expression. Taken together our results suggest that
-irradiation induces endothelial cell apoptosis predominantly via the activation of p38 MAPK, and VEGF protects endothelial cells against
-irradiation predominantly via the PI3K-Akt-Bcl-2 signaling pathway.
Received for publication, May 24, 2004
, and in revised form, July 29, 2004.
* This work was supported by National Institutes of Health Grant DE 13161 (to P. J. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: The University of Michigan School of Dentistry, 1011 N. University Ave., Rm. 1234, Ann Arbor, MI 48109. Tel.: 734-763-3311; Fax: 734-763-5142; E-mail: neovas{at}umich.edu.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Le, R. Damico, M. Damarla, A. Boueiz, H. H. Pae, J. Skirball, E. Hasan, X. Peng, A. Chesley, M. T. Crow, et al.
Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury
J Appl Physiol,
October 1, 2008;
105(4):
1282 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kumar, Q. Gao, Y. Ning, Z. Wang, P. H. Krebsbach, and P. J. Polverini
Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone
Mol. Cancer Ther.,
July 1, 2008;
7(7):
2060 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes,
January 1, 2008;
57(1):
158 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Gills, S. S. Castillo, C. Zhang, P. A. Petukhov, R. M. Memmott, M. Hollingshead, N. Warfel, J. Han, A. P. Kozikowski, and P. A. Dennis
Phosphatidylinositol Ether Lipid Analogues That Inhibit AKT Also Independently Activate the Stress Kinase, p38{alpha}, through MKK3/6-independent and -dependent Mechanisms
J. Biol. Chem.,
September 14, 2007;
282(37):
27020 - 27029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yang, L. Lin, J.-X. Chen, C. R. Lee, J. M. Seubert, Y. Wang, H. Wang, Z.-R. Chao, D.-D. Tao, J.-P. Gong, et al.
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-{alpha} via MAPK and PI3K/Akt signaling pathways
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H142 - H151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kumar, I. K. Coltas, B. Kumar, D. B. Chepeha, C. R. Bradford, and P. J. Polverini
Bcl-2 Protects Endothelial Cells against {gamma}-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release
Cancer Res.,
February 1, 2007;
67(3):
1193 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ferrari, G. Pintucci, G. Seghezzi, K. Hyman, A. C. Galloway, and P. Mignatti
VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis
PNAS,
November 14, 2006;
103(46):
17260 - 17265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-U. Kim, S. S. Kang, S.-A. Yoo, K.-H. Hong, D.-G. Bae, M.-S. Lee, S. W. Hong, C.-B. Chae, and C.-S. Cho
Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation
J. Immunol.,
October 15, 2006;
177(8):
5727 - 5735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Goldberg, D. M. Rocke, C. Schwietert, S. R. Berglund, A. Santana, A. Jones, J. Lehmann, R. Stern, R. Lu, and C. Hartmann Siantar
Human In vivo Dose-Response to Controlled, Low-Dose Low Linear Energy Transfer Ionizing Radiation Exposure.
Clin. Cancer Res.,
June 15, 2006;
12(12):
3723 - 3729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Warfel, E. R. Lepper, C. Zhang, W. D. Figg, and P. A. Dennis
Importance of the Stress Kinase p38{alpha} in Mediating the Direct Cytotoxic Effects of the Thalidomide Analogue, CPS49, in Cancer Cells and Endothelial Cells.
Clin. Cancer Res.,
June 1, 2006;
12(11):
3502 - 3509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Aziz, M. Nihal, V. X. Fu, D. F. Jarrard, and N. Ahmad
Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins
Mol. Cancer Ther.,
May 1, 2006;
5(5):
1335 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-S. Choi, J. T. Park, and J. S. Dumler
Anaplasma phagocytophilum Delay of Neutrophil Apoptosis through the p38 Mitogen-Activated Protein Kinase Signal Pathway
Infect. Immun.,
December 1, 2005;
73(12):
8209 - 8218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. K. Hong, P. Kumar, L. Wang, B. Damania, M. L. Gulley, H.-J. Delecluse, P. J. Polverini, and S. C. Kenney
Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell Lines
J. Virol.,
November 15, 2005;
79(22):
13984 - 13992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-C. Chang, C.-J. Huang, K. Tam, S.-F. Chen, K. T. Tan, M.-S. Tsai, T.-N. Lin, and S.-K. Shyue
Stabilization of Hypoxia-inducible Factor-1{alpha} by Prostacyclin under Prolonged Hypoxia via Reducing Reactive Oxygen Species Level in Endothelial Cells
J. Biol. Chem.,
November 4, 2005;
280(44):
36567 - 36574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ferguson, L. E. Rodriguez, J. P. Palma, M. Refici, K. Jarvis, J. O'Connor, G. M. Sullivan, D. Frost, K. Marsh, J. Bauch, et al.
Antitumor Activity of Orally Bioavailable Farnesyltransferase Inhibitor, ABT-100, Is Mediated by Antiproliferative, Proapoptotic, and Antiangiogenic Effects in Xenograft Models
Clin. Cancer Res.,
April 15, 2005;
11(8):
3045 - 3054.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.